Model Answer: Henrietta's HeLa cells were the first immortal human cell line, meaning they could reproduce indefinitely in laboratory conditions. These cells revolutionized medical research by enabling scientists to test treatments for polio, cancer, and other diseases. The cells helped develop the polio vaccine, contributed to cancer research, and advanced our understanding of cell biology. Their significance lies in the fact that they provided a consistent, reliable tool for medical research that saved countless lives, though this occurred without Henrietta's knowledge or consent.

Model Answer: The use of Henrietta's cells without consent raises serious ethical concerns about patient rights and informed consent. In 1951, patients weren't routinely asked for permission to use tissue samples, reflecting different medical practices of the time. This case highlights questions about who owns biological materials after they leave the body, whether patients should benefit financially from profitable discoveries made from their cells, and the importance of informed consent in medical procedures. It also raises issues about racial inequality in healthcare and how marginalized communities have historically been exploited in medical research.

Model Answer: The Lacks family experienced significant emotional and financial hardship related to Henrietta's cells. For decades, they were unaware that her cells were being used in research and had generated millions of dollars in profits for companies. When they learned about HeLa cells, many family members felt betrayed and exploited. They struggled financially while others profited from Henrietta's biological contribution. The family also dealt with confusion about scientific concepts and felt that Henrietta's story and their family's suffering had been overlooked. The situation highlighted disparities in healthcare access, as some family members couldn't afford health insurance despite their mother's cells helping develop treatments.

Model Answer: Henrietta's story reflects systemic inequalities in American healthcare. As a poor African American woman in 1951, she received treatment at Johns Hopkins Hospital, one of the few places that treated Black patients. The fact that her cells were taken without consent reflects how marginalized communities have historically been subjects of medical research without full participation in its benefits. The Lacks family's later inability to afford healthcare while HeLa cells generated profits demonstrates ongoing economic disparities. The story also shows how scientific achievements often overlook the human stories behind them, particularly when those humans are from disadvantaged communities. Rebecca Skloot's book itself represents an effort to restore Henrietta's humanity and acknowledge her family's experience.

Model Answer: Modern medicine can learn several crucial lessons from Henrietta's story. First, the absolute importance of informed consent - patients must understand what will happen to their biological materials. Second, the need for benefit-sharing when profitable discoveries are made from patient samples. Third, the importance of cultural competency and clear communication between healthcare providers and patients from diverse backgrounds. Fourth, the value of recognizing and honoring the human stories behind scientific breakthroughs. These lessons have already influenced current practices through stronger consent protocols, ethics review boards, and discussions about compensation for tissue donors. The story reminds us that behind every medical advance are real people whose contributions should be acknowledged and respected.